Hospital Universitario de la Princesa -ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

2023

  1. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

    Journal of Medical Virology, Vol. 95, Núm. 12

2022

  1. Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781

2017

  1. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2014

  1. Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

    Clinical Cancer Research, Vol. 20, Núm. 22, pp. 5697-5707

2012

  1. Molecular pathways: Hypoxia response in immune cells fighting or promoting cancer

    Clinical Cancer Research, Vol. 18, Núm. 5, pp. 1207-1213

  2. The HIF-1α hypoxia response in tumor-infi ltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy

    Cancer Discovery, Vol. 2, Núm. 7, pp. 608-623

2011

  1. New trends in immunotherapy

    Inmunologia

2009

  1. Hacia un programa de Garantía Externa de Calidad para Laboratorios de Inmunología Diagnóstica asociado a la Sociedad Española de Inmunología (GECLID-SEI)

    Inmunologia

1997

  1. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules

    Immunological Reviews, Vol. 155, pp. 165-174

  2. The CD94/NKG2-A Inhibitory Receptor Complex Is Involved in Natural Killer Cell-Mediated Recognition of Cells Expressing HLA-G1

    Journal of Immunology, Vol. 158, Núm. 12, pp. 5736-5743

1996

  1. Biochemical and Serologic Evidence for the Existence of Functionally Distinct Forms of the CD94 NK Cell Receptor

    Journal of Immunology, Vol. 157, Núm. 12, pp. 5367-5374

  2. Expression and function of α4/β7 integrin on human natural killer cells

    Immunology, Vol. 89, Núm. 1, pp. 96-104

  3. Functional analysis of α1β1 integrin in human natural killer cells

    European Journal of Immunology, Vol. 26, Núm. 9, pp. 2023-2029

  4. Functional resemblance between the Ig-related NK cell receptors specific for HLA class I molecules and the CD94 C-type lectin

    Chemical Immunology, Vol. 64, pp. 116-134

1995

  1. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen

    Journal of Immunology, Vol. 154, Núm. 11, pp. 5779-5788

1993

  1. Signaling through the LFA‐1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor‐α production in natural killer cells

    European Journal of Immunology, Vol. 23, Núm. 8, pp. 1859-1865

  2. Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-α production involving the LFA-1 integrin

    Journal of Immunology, Vol. 151, Núm. 7, pp. 3420-3429